MarketInOut Stock Screener Log In | Sign Up

Mangalam Drugs & Organics Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Mangalam Drugs & Organics Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization443.19 mln
Float14.85 mln

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-4.46
Highly reliable

Relative Strength

23 / 100
Significantly lagging

Debt / Equity

1.08
Elevated leverage

Pre-Tax Margin

-18%
Loss-making

ROE

-30.22
Deeply negative

Business Description

Mangalam Drugs & Organics Limited is a Mumbai-based pharmaceutical manufacturer founded in 1972 that produces and sells active pharmaceutical ingredients, chemical intermediates, and specialty chemicals in India. Its product range spans several medical treatment areas, including malaria, HIV, high blood pressure, inflammation, and bacterial infections. The company also produces a variety of organic, inorganic, and industrial chemicals through its operations and subsidiary.

Key Fundamentals

EPS-19.53
ROE-30.22
RPS150
ROIC-8.84
ROA-11.42
Interest Cover-1.69
EBITDA, mln-86.48
EV / EBITDA-18.55
EV / EBIT-6.06
Revenue, mln2,324
EV / Revenue0.69

Quote Details

Last 28.73
Change 0.71 (2.53%)
Open 29.01
Volume 473
Turnover 13,589
Average Volume 5,937.76

Financial Ratios

Pre-Tax Profit Margin-18
Current Ratio0.79
Price / Book0.47
Price / Tangible Book0.69
Price / Cash Flow5.94
Price / Free Cash Flow23.94
Debt / Equity1.08
Price / Sales0.21

Financial Strength

Altman Z-Score0.64
Piotroski F-Score 3 / 9
Beneish M-Score-4.46
Price to Intrinsic Value2.91
Shiller PE Ratio7.80

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.44% 19 / 100   
1 Month -10.16% 37 / 100   
2 Months 5.51% 77 / 100   
6 Months 3.35% 66 / 100   
1 Year -58.39% 6 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog